key: cord-0758579-yaapimwn
authors: Wacharapluesadee, S.; Kaewpom, T.; Ampoot, W.; Ghai, S.; Khamhang, W.; Worachotsueptrakun, K.; Wanthong, P.; Nopvichai, C.; Supharatpariyakorn, T.; Putcharoen, O.; Paitoonpong, L.; Suwanpimolkul, G.; Jantarabenjakul, W.; Hemachudha, P.; Krichphiphat, A.; Buathong, R.; Plipat, T.; Hemachudha, T.
title: Evaluating efficiency of pooling specimens for PCR-based detection of COVID-19
date: 2020-05-06
journal: nan
DOI: 10.1101/2020.05.02.20087221
sha: 5ffe9a1602b9c0959380eb15dfb78906ced112b4
doc_id: 758579
cord_uid: yaapimwn

In the age of a pandemic, such as the ongoing one caused by SARS-CoV-2, the world faces limited supply of tests, PPE and reagents, and factories are struggling to meet the growing demands. This study aimed to evaluate the efficacy of pooling specimen for testing of SARS-CoV-2 virus, to determine whether costs and resource savings could be achieved without impacting the sensitivity of the testing. Ten specimens were pooled for testing, containing either one or two known positive specimen of varying viral concentrations. Pooling specimens did not affect the sensitivity of detecting SARS-CoV-2, and the PCR cycle threshold (Ct) between testing of pooling specimen and subsequent individual testing was not significantly different using paired t-test. This study also identified cost savings garnered from pooling of specimen for testing at 4 differing prevalence rates, ranging from 0.1-10%. Pooling specimens to test for COVID-19 infection in low prevalence areas or in low risk population can dramatically decrease the resources burden on lab operations by up to 80%. This paves the possibility for large-scale population screening, allowing for assured policy decisions by governmental bodies to ease lockdown restrictions in areas with low incidence of infection, or with lower risk populations.

In the age of a pandemic, such as the ongoing one caused by SARS-CoV-2, the world faces limited supply of tests, PPE and reagents, and factories are struggling to meet the growing demands. This study aimed to evaluate the efficacy of pooling specimen for testing of SARS-CoV-2 virus, to determine whether costs and resource savings could be achieved without impacting the sensitivity of the testing. Ten specimens were pooled for testing, containing either one or two known positive specimen of varying viral concentrations. Pooling specimens did not affect the sensitivity of detecting SARS-CoV-2, and the PCR cycle threshold (Ct) between testing of pooling specimen and subsequent individual testing was not significantly different using paired t-test. This study also identified cost savings garnered from pooling of specimen for testing at 4 differing prevalence rates, ranging from 0.1-10%.

Pooling specimens to test for COVID-19 infection in low prevalence areas or in low risk population can dramatically decrease the resources burden on lab operations by up to 80%.

This paves the possibility for large-scale population screening, allowing for assured policy decisions by governmental bodies to ease lockdown restrictions in areas with low incidence of infection, or with lower risk populations.

KEYWORDS: COVID-19; SARS-CoV-2; pooling specimen; PCR; real-time PCR; cost efficiency . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 6, 2020. . https://doi.org/10.1101/2020.05.02.20087221 doi: medRxiv preprint

The ongoing COVID-19 pandemic has highlighted the need for early diagnosis of emerging infectious diseases to better contain an outbreak. Testing for SARS-CoV-2, the virus that causes COVID-19, has been limited due to factors including high cost and low availability of reagents, lack of personal protective equipment (PPE) and other consumables, and the sheer volume of samples be tested. Factories have been struggling to meet the growing demands for these necessities 1,2 . To date, countries that are able to screen patients swiftly have fared better in containing the COVID-19 outbreak and suppressing the mortality rate associated with the disease 3 . The rapid diagnosis of COVID-19 in both symptomatic and asymptomatic patients can shed light on transmission patterns and facilitate contact tracing 2,3 . Large scale population screening for COVID-19 infection is generally considered a necessary part of an exit strategy from the coronavirus lockdown, and in reinforcing infection control measures in hospitals and among health care workers.

Specimen pooling is a method of screening large number of patients for an infection, and typically involves combining multiple patient specimens into a single test sample, then testing multiple such samples. This approach has the advantage of cost-effectiveness and speed, and was used to retrospectively screen for COVID-19 in specimens that were negative for common respiratory viruses earlier in the course of the pandemic in the United States 4 , and in France to rapidly screen multiple returning expatriates from China with low suspicion of infection 5 . Specimen pooling has also been used in screening efforts for several other infectious diseases, including donated blood samples for HIV 6-9 .

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 6, 2020. Pooling nasopharyngeal and throat swab (NT) specimens would be more economical than individually testing all specimens from low-risk populations, particularly in limited-resource settings 10 . The current study was undertaken to compare laboratory results from sample pooling (10 samples) with the standard real-time polymerase chain reaction (qPCR) testing without pooling, as a means of preparing for a broad pooling-based screening effort to ensure that detection accuracy will not be compromised.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 6, 2020. This study used magnetic extraction-based assay (NUCLISENS®, easyMag®, bioMérieux, Marcy-l'Étoile, France) based on the Boom method to extract DNA and RNA, which allows a maximum specimen volume of 1.0mL 11 . By using magnetic beads to capture DNA and RNA during the extraction step, pooling 10 specimens of 0.1mL each (total of 1.0 mL extraction sample) can result in the same extraction capability as 0.1mL if the elution volume at the end is equal and there is no PCR interference from the specimen such as lipid, protein or cell debris.

Two pooling ratios were evaluated in this study, termed 1X and 2X. In the 1X ratio, 0.1mL of NT-VTM from one SARS-CoV-2 positive specimen was combined with 0.9 mL pooled . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 6, 2020. . https://doi.org/10.1101/2020.05.02.20087221 doi: medRxiv preprint 7 negative NT-VTM, thus modeling a 10% infection rate. Correspondingly, in the 2X ratio, 0.1mL of NT-VTM each from two SARS-CoV-2 positive specimens were pooled with 0.8 mL pooled negative NT-VTM, thus modeling a 20% infection rate (see Figure 1 ). All 1.0 mL pooled samples in this study were then processed for nucleic acid extraction using NUCLISENS® easyMAG® instrument (bioMérieux). In addition, 0.1mL of the same positive specimens that were used in the pooled samples were re-tested for sensitivity comparison using a separate extraction system (EZ1, Qiagen, Hilden, Germany). Real-time PCR (qPCR) for detection of SARS-CoV-2 was performed using a commercial kit which targets the ORF1ab gene as per the manufacturer's protocol (BGI, Shenzhen, China). The protocol's stated limit of detection of ORF1ab real-time PCR was 100 copies/mL and the cutoff PCR cycle threshold (Ct) was 38.

Previously positive specimens with high and low-concentrations of RNA, as determined by PCR cycle threshold (Ct) values at the time of detection, were selected to determine the effect of viral load on pooling to ensure sensitivity and accuracy of the assays is maintained (Table 1) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 6, 2020. The sensitivity of viral RNA detection for each pool was compared with the sensitivity of PCR results for the individually tested positive specimen in that pool. For 2X ratio pools, the positive specimen with the lower Ct value, when individually tested, was used for comparison (Table 1) .

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 6, 2020. . https://doi.org/10.1101/2020.05.02.20087221 doi: medRxiv preprint

All 1X ratio pools were positive, with Ct value difference within a range of -1.36 to +1.59 when compared to individual (non-pooled) testing. Negative and positive values of Ct indicates higher and lower sensitivity of pooling, respectively. All 2X ratio pools were positive, with Ct value difference within a range of -1.72 to +1.81 when compared to individual (non-pooled) testing (Table 1) . Statistical paired t-test was calculated to compare the Ct value differences between pooled (including all patterns in Figure 1) Cost effectiveness of the pooling strategy was calculated, based on varying disease prevalence rates (0.1-10%) ( Table 2 ). Pooling appears most cost-effective when testing among populations with lower COVID-19 prevalence. Estimated laboratory costs were reduced from $35 per patient to $3.85, $6.85, $17.54, $26.30 at prevalences of COVID-19 in the tested population of 0.1%, 1, 5%, and 10% respectively. By this estimation, pooledspecimen testing of 1,000,000 subjects in a population with 1% COVID-19 prevalence would save approximately $28.15 million, assuming evenly distributed positive specimens in each pool ( Table 2) .

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 6, 2020. 

This study demonstrates that pooling specimens does not compromise the sensitivity of detecting SARS-CoV-2, regardless of viral load. The lowest viral concentration used in this study was at Ct 35.49 which was detected from both pooled and individual testing. Ct value more than 35 was considered weakly positive, and the effect of pooling on these samples will need to be further studied. In 2X ratio pooling, RT PCR testing detected higher viral concentrations (lower PCR Ct) compared to those of the corresponding positive specimens when tested individually. This suggests that pooling specimens did not lower the sensitivity of PCR testing but actually increased the viral concentration when more than one positive sample was present in the same pool which combined the viral amount from 2 samples in the same extraction tube. The nucleic extraction system used in this study allowed nucleic acid extraction from 1.0 mL of NT specimens without reducing the sensitivity as compared to 0.1 mL of individual extraction. Further, similar PCR Ct values (within +/-2 Ct; statistically not significant) between pooled and non-pooled specimens indicated there was no interference of PCR inhibitor from 1.0 mL pooled specimens in one extraction tube.

Beyond maintaining accuracy, specimen pooling will almost certainly reduce cost. For example, if 1% of the population is infected, pooling 10 specimens can reduce the cost of laboratory operation by about 80% (Table 2 ). However, in the case of 10% prevalence, pooling specimens will only save 24.87%, as positive pooled samples will need to be individually tested. Thus, this is especially useful in areas with low prevalence rates, or when conducting pro-active surveillance in areas of low infection rate. Proactive surveillance, particularly in asymptomatic cases, remains a challenge to overcome in order to exit lockdown, where screening on a massive scale is required.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 6, 2020. . https://doi.org/10.1101/2020.05.02.20087221 doi: medRxiv preprint A previous study found that pooling at ratio of 1 to 5 (50 μL of each specimen for total of 250 μL pooled extraction) retained accuracy of the test and resulted in greater efficiency of test resources 10 as well as demonstrating that when the prevalence of COVID-19 is 1%, the optimal specimen pool size is 11 with an overall increase in testing efficiency calculated at 400%. In this study, a 10-specimen pool size (100 μL each specimen) was chosen based on the capacity of the RNA extraction system in the laboratory where this study was performed, and the result was similar to 5 samples pooling 10 .

A limitation of this study is the maximum number of two positive specimens in the 10specimen pool. In theory, more positive specimens in a pool could decrease the sensitivity of qPCR as it would result in too many viral copies, causing an insufficiency of PCR enzyme and other reagents in the mix to amplify all the viral copies. Practically, however, this does not affect the overall testing results, since positive pools would require individual testing in any case.

Rapid identification of SARS-CoV-2 infection is crucial to curb the COVID-19 pandemic. The current gold standard for testing SARS-CoV-2 is real-time PCR, which requires resources that are currently limited, along with specialized equipment and technically skilled labor.

Shortage of testing reagents and equipment in countries where there is no capability to produce their own tests may result in delays in testing and result in reduced effectiveness in containing the outbreak. Pooled specimen testing would enable substantial savings in reagent costs, technical burden and time to generate laboratory results.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 6, 2020. . https://doi.org/10.1101/2020.05.02.20087221 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 6, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 6, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 6, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 6, 2020. *% of pool with no infection = (% of non-infected samples in one pool)^number of samples per pools . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 6, 2020. . https://doi.org/10.1101/2020.05.02.20087221 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 6, 2020. . https://doi.org/10.1101/2020.05.02.20087221 doi: medRxiv preprint Figure 1 Illustrates the experimental design of the pooling strategies tested in this study

Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide

Fair allocation of scarce medical resources in the time of Covid-19

Countries test tactics in 'war'against COVID-19

Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2

Testing the repatriated for SARS-Cov2

Hospital's Excellent Center Program, National Research Council of Thailand (NRCT), and the Biological Threat Reduction Program (BTRP) of the US Defense Threat Reduction Agency (DTRA). We would also like to acknowledge Dr. Paul Gaudio (Yale University) for his kind assistance in the critical editing of this manuscript.